BURDEN AND IMPACT

RE-KINECT: Real-World Dyskinesia Screening Study

Join Dr. Andrew Cutler as he shares insights from the RE-KINECT study, including findings on the prevalence and impact of possible tardive dyskinesia (TD) in patients in outpatient psychiatry practices in the United States. 
Faculty have been compensated by Neurocrine Biosciences, Inc.
Empty space, drag to resize
Write your awesome label here.

MED-MSL-TD-US-0404

Up Next
Burden and Impact of Tardive Dyskinesia in Older Adults
Tune in with Dr. Amita Patel as she shares her insights into what tardive dyskinesia is, its risk factors, and its impact on older adults and caregivers, highlighting the importance of early recognition and management of this frequently underdiagnosed movement disorder in the long-term care setting.
This podcast has been sponsored and co-developed by Neurocrine Biosciences, Inc. This podcast is for educational purposes only and is not intended to promote any specific product. The speaker is presenting on behalf of and is a paid consultant for Neurocrine Biosciences. The information provided herein is based upon the healthcare provider’s clinical judgment and personal experience.
Up Next
Mechanism of Disease: Tardive Dyskinesia
Discover the proposed mechanism of disease underlying tardive dyskinesia in this educational animation.

Your Resources on Tardive Dyskinesia and Other DIMDs

These free educational resources are sponsored and developed by Neurocrine Biosciences, Inc.
Discover TD®
In this interactive application, users can differentially diagnose and develop appropriate management plans for hypothetical, virtual patients with various movement disorders.
DIMD Course
Enroll in this free, virtual self-paced learning platform delving into various clinical aspects of the most common DRBA-induced movement disorders and earn a recognized certificate of completion. 

Media Platforms

TD Dialogues® Podcast
Hear from experts in insightful conversations as they discuss the challenges of recognizing TD and share real-world strategies to effectively support patients in managing symptoms.
Neurocrine Medical: Brave Science™ YouTube Channel
This channel features educational videos designed to further understanding of TD, including content on the proposed mechanism of disease in TD and differentiating TD from drug-induced parkinsonism.

Explore the DIMD Ecosystem Library

Want to explore our collection of DIMD educational resources on your own? Use the link below to view the full content library.
This educational content was sponsored and developed by Neurocrine Biosciences, Inc. This non-CME program is intended to provide general information about drug-induced movement disorders and not medical advice for any particular patient.

Copyright © 2026

MED-MI-TD-US-0276